A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study - PubMed (original) (raw)

Comparative Study

A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study

Kumar B Rajan et al. J Gerontol A Biol Sci Med Sci. 2017.

Abstract

Background: Cognitive changes during the preclinical phase of Alzheimer's disease (AD) dementia have been characterized among European Americans (EAs), but studies of preclinical changes among African Americans (AAs) are notably absent.

Methods: Preclinical changes in cognition before the development of AD dementia and mild cognitive impairment over a period of 18 years were examined using change points in a biracial sample of 2,125 older adults.

Results: Of 2,125 participants, 442 (21%) developed AD dementia and 661 (31%) developed mild cognitive impairment. A cognitive change point occurred between 4 and 5 years before the clinical diagnosis of AD dementia. Differences between AAs and EAs were observed: EAs had a higher starting level of composite cognitive function, and a change point occurred 4.3 years before AD dementia among AAs and 4.7 years among EAs. The slope of cognitive decline after the change point among those developing clinical AD dementia was significantly greater among EAs (0.233 units/y) than among AAs (0.171 units/y; p < .001). This difference in slope of cognitive decline persisted after diagnosis of AD dementia so that at the conclusion of observation the difference in average cognitive level was reversed. AAs without cognitive impairment had a lower average baseline of cognition than EAs, but the slopes of cognitive decline were similar.

Conclusions: A prominent change to a steeper slope of cognitive decline occurs between 4 and 5 years prior to the diagnosis of AD dementia. The slope of cognitive decline after the change point is steeper among EAs than AAs.

Keywords: Alzheimer’s disease; Cognitive change; Mild cognitive impairment.

© The Author 2017. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Time-specific mean and 95% CIs for change in cognitive function among AA and EA with no cognitive impairment, and developing AD dementia (a) and MCI (b). AA = African Americans; AD = Alzheimer’s disease; EA = European Americans; MCI = mild cognitive impairment.

Figure 2.

Figure 2.

A 12-y course of change in cognitive function of a hypothetical participant with clinical diagnosis for AD dementia (a) and MCI (b) at year 8 for AA and EA. AA = African Americans; AD = Alzheimer’s disease; EA = European Americans; MCI = mild cognitive impairment.

References

    1. Rajan KB, Wilson RS, Weuve J, Barnes LL, Evans DA. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology. 2015;85:898–904. doi:10.1212/WNL.0000000000001774 -PMC -PubMed
    1. Dilworth-Anderson P, Hendrie HC, Manly JJ, Khachaturian AS, Fazio S; Social, Behavioral and Diversity Research Workgroup of the Alzheimer’s Association Diagnosis and assessment of Alzheimer’s disease in diverse populations. Alzheimers Dement. 2008;4:305–309. doi:10.1016/j.jalz.2008.03.001 -PubMed
    1. Early DR, Widaman KF, Harvey D, et al. Demographic predictors of cognitive change in ethnically diverse older persons. Psychol Aging. 2013;28:633–645. doi:10.1037/a0031645 -PMC -PubMed
    1. Atkinson HH, Cesari M, Kritchevsky SB, et al. Predictors of combined cognitive and physical decline. J Am Geriatr Soc. 2005;53:1197–1202. doi:10.1111/j.1532-5415.2005.53362.x -PubMed
    1. Masel MC, Peek MK. Ethnic differences in cognitive function over time. Ann Epidemiol. 2009;19:778–783. doi:10.1016/j.annepidem.2009.06.008 -PMC -PubMed

Publication types

MeSH terms

LinkOut - more resources